Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

Teva image

Teva to ditch R&D in cancer and women’s health

October 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics

Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

News
Mylan image

Mylan buys Abbott generics

July 15, 2014
Manufacturing and Production, Sales and Marketing Abbott, Mylan, generics, new mylan

Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …

News
Dr Phillip Frost image

Teva chairman stepping down amid revamp

June 19, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …

News
Teva image

Teva to close half its sites

June 17, 2014
Manufacturing and Production, Sales and Marketing Jobs, Teva, cuts, generics, manufacturing

Teva Pharmaceutical Industries is to close around half of its 75 manufacturing sites within the next five years, chief financial …

News
Teva image

Teva considers up to 27 plant closures

May 13, 2014
Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics

Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …

News

FDA: India needs more inspectors

February 25, 2014
Manufacturing and Production FDA, India, generics, hamburg

The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …

News
FDA image

FDA given $20 million for generic testing

February 24, 2014
Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg

The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …

News

Europe poised for generic Symbicort

February 24, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

News
Shire HQ

Shire’s Vyvanse could bring in new revenue

February 14, 2014
Medical Communications, Research and Development, Sales and Marketing ADHD, Shire, Vyvanse, binge eating, generics

News
Teva image

Teva under investigation for marketing practices

February 12, 2014
Sales and Marketing Azilect, Copaxone, Teva, fines, generics

Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …

News

Merck KGaA pushes biosimilars

February 12, 2014
Research and Development, Sales and Marketing Dr Reddy's, Merck KGaA, biosimilars, dr reddys, generics

Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …

News
Sovaldi image

Gilead to allow cheaper generics of new hep C drug

February 6, 2014
Manufacturing and Production, Sales and Marketing Gilead, India, generics, hep C, s&m, sofosbuvir, sovaldi

Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …

News
aurobindo image

Actavis makes Aurobindo sale

January 21, 2014
Sales and Marketing Actavis, Aurobindo, India, generics

Actavis is to sell its commercial operations in seven European countries to Aurobindo Pharma in a bid to put more …

News
China image

Actavis: China is ‘too risky’

January 17, 2014
Sales and Marketing Actavis, China, bribery, generics, risky

The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …

News
Erez Vigodman image

Teva names new chief executive

January 9, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Levin, Teva, erez vigodman, generics

The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026